A debate. «Orbitando» en torno al abordaje de la angina estable. Perspectiva del clínico

  1. David Vivas 1
  1. 1 Instituto Cardiovascular, Hospital Clínico San Carlos
Revista:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Any de publicació: 2024

Volum: 6

Número: 3

Pàgines: 238-239

Tipus: Article

DOI: 10.24875/RECIC.M24000452 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Altres publicacions en: REC: Interventional Cardiology

Referències bibliogràfiques

  • Al-Lamee R, Thompson D, Dehbi H-M, et al. Percutaneous coronary intervention in stable angina (ORBITA):a double-blind, randomised controlled trial. Lancet. 2018;391:31-40.
  • Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. N Engl J Med. 2023;389:2319-2330.
  • Nowbar AN, Rajkumar C, Foley M, et al. A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications:design and rationale of the ORBITA-2 trial. EuroIntervention. 2022;17:1490-1497.
  • Al-Lamee R, Howard JP, Shun-Shin MJ, et al. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease. Circulation. 2018;138:1780-1792.
  • Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-477.
  • Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization:A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e18-e114.
  • Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395-1407.
  • Spertus JA, Jones PG, Maron DJ, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. 2020;382:1408-1419.
  • Teoh Z, Al-Lamee RK. COURAGE, ORBITA, and ISCHEMIA. Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Intervent Cardiol Clin. 2020;9:469-482.
  • 1rnold SV, Jang J-S, Tang F, Graham G, Cohen DJ, Spertus JA. Prediction of residual angina after percutaneous coronary intervention. Eur Heart J Qual Care Clin Oucomes. 2015;1:23-30.
  • McCreanor V, Nowbar A, Rajkumar C, et al. Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease:an economic evaluation of the ORBITA trial. BMJ Open. 2021;11:e044054.
Fuente de los datos: Dialnet